journal article·2023-03Open access

A guide to preclinical evaluation of hydrogel-based devices for treatment of cartilage lesions

Peyman Karami, Theofanis Stampoultzis, Yanheng Guo, Dominique P. Pioletti

Acta Biomaterialia· Volume 158

Abstract

The drive to develop cartilage implants for the treatment of major defects in the musculoskeletal system has resulted in a major research thrust towards developing biomaterial devices for cartilage repair. Investigational devices for the restoration of articular cartilage are considered as significant risk materials by regulatory bodies and therefore proof of efficacy and safety prior to clinical testing represents a critical phase of the multidisciplinary effort to bridge the gap between bench and bedside. To date, review articles have thoroughly covered different scientific facets of cartilage engineering paradigm, but surprisingly, little attention has been given to the preclinical considerations revolving around the validation of a biomaterial implant. Considering hydrogel-based cartilage products as an example, the present review endeavors to provide a summary of the critical prerequisites that such devices should meet for cartilage repair, for successful implantation and subsequent preclinical validation prior to clinical trials. Considerations pertaining to the choice of appropriate animal model, characterization techniques for the quantitative and qualitative outcome measures, as well as concerns with respect to GLP practices are also extensively discussed. This article is not meant to provide a systematic review, but rather to introduce a device validation-based roadmap to the academic investigator, in anticipation of future healthcare commercialization. STATEMENT OF SIGNIFICANCE: There are significant challenges around translation of in vitro cartilage repair strategies to approved therapies. New biomaterial-based devices must undergo exhaustive investigations to ensure their safety and efficacy prior to clinical trials. These considerations are required to be applied from early developmental stages. Although there are numerous research works on cartilage devices and their in vivo evaluations, little attention has been given into the preclinical pathway and the corresponding approval processes. With a focus on hydrogel devices to concretely illustrate the preclinical path, this review paper intends to highlight the various considerations regarding the preclinical validation of hydrogel devices for cartilage repair, from regulatory considerations, to implantation strategies, device performance aspects and characterizations.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Knee injuries and reconstruction techniques · Total Knee Arthroplasty Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Molecular transport in articular cartilage—what have we learned from the past 50 years?10.1038/s41584-018-0033-5 ↗
2. The mechanobiology of articular cartilage: bearing the burden of osteoarthritis10.1007/s11926-014-0451-6 ↗
3. The structure and function of the pericellular matrix of articular cartilage10.1016/j.matbio.2014.08.009 ↗
4. Basic science of articular cartilage10.1016/j.csm.2017.02.001 ↗
5. Unlike bone, cartilage regeneration remains elusive10.1126/science.1222454 ↗
6. Thoughts on cartilage tissue engineering: a 21st century perspective
7. III, Osteochondral allograft transplantation of the knee in patients with an elevated body mass index10.1177/1947603518754630 ↗
8. Long-term follow-up of revision osteochondral allograft transplantation of the ankle10.1177/1071100717750578 ↗
9. Long-term outcomes after osteochondral autograft transfer: a systematic review at mean follow-up of 10.2 years10.1016/j.arthro.2015.11.037 ↗
10. Long-term outcome of grade III and IV chondral injuries of the knee treated with Steadman microfracture technique
11. Microfracture for the treatment of cartilage defects in the knee joint–a golden standard?10.1016/j.jcot.2016.06.015 ↗
12. Factors predictive of outcome 5 years after matrix-induced autologous chondrocyte implantation in the tibiofemoral joint10.1177/0363546513484696 ↗
13. Regulatory framework for advanced therapy medicinal products in Europe and United States10.3389/fphar.2019.00921 ↗
14. Regulatory challenges for cartilage repair technologies10.1177/1947603512460756 ↗
15. Amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use as regards advanced therapy medicinal products
16. 2014
17. Marketing regulatory oversight of advanced therapy medicinal products (ATMPs) in Europe: the EMA/CAT perspective10.1007/978-3-319-18618-4_6 ↗
18. Preclinical animal models in single site cartilage defect testing: a systematic review10.1016/j.joca.2008.11.008 ↗
19. 2010
20. Guideline on the risk-based approach according to annex I, part IV of Directive 2001/83/EC applied to Advanced therapy medicinal products, Committee for Advanced Therapies (CAT) (EMA/CAT/CPWP/686637/2011) (February 2013).
21. Key considerations on the development of biodegradable biomaterials for clinical translation of medical devices: with cartilage repair products as an example
22. Design control requirements for medical device development10.1177/2150135111422720 ↗
23. Design control for clinical translation of 3D printed modular scaffolds10.1007/s10439-015-1270-2 ↗
24. Medical device risk management10.1016/B978-0-12-820960-8.00005-8 ↗
25. Medical device product verification and validation
26. Design and clinical application of injectable hydrogels for musculoskeletal therapy10.1002/btm2.10295 ↗
27. Premarket Approval of Medical Devices, 2020. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-814.
28. Premarket Approval (PMA), 2019. https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/premarket-approval-pma.
29. Food · 2011 · 1
30. Preclinical studies for cartilage repair: recommendations from the International Cartilage Repair Society10.1177/1947603511401905 ↗
31. Goebel · 2017 · 189
32. Systematic comparison of biomaterials-based strategies for osteochondral and chondral repair in large animal models10.1002/adhm.202100878 ↗
33. Preclinical good laboratory practice-compliant safety study to evaluate biodistribution and tumorigenicity of a cartilage advanced therapy medicinal product (ATMP)10.1186/s12967-015-0517-x ↗
34. A road map to commercialization of cartilage therapy in the United States of America10.1089/ten.teb.2015.0147 ↗
35. Current concepts and perspectives for articular cartilage regeneration10.1186/s40634-022-00498-4 ↗
36. Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity
37. Silk granular hydrogels self-reinforced with regenerated silk fibroin fibers
38. Composite double-network hydrogels to improve adhesion on biological surfaces10.1021/acsami.8b10735 ↗
39. Articular cartilage regeneration using acellular bioactive affinity-binding alginate hydrogel: a 6-month study in a mini-pig model of osteochondral defects10.1016/j.jot.2018.08.003 ↗
40. Recent advances of injectable hydrogels for drug delivery and tissue engineering applications10.1016/j.polymertesting.2019.106283 ↗
41. Translational applications of hydrogels10.1021/acs.chemrev.0c01177 ↗
42. An intrinsically-adhesive family of injectable and photo-curable hydrogels with functional physicochemical performance for regenerative medicine10.1002/marc.202000660 ↗
43. Injectable hydrogel based on modified gelatin and sodium alginate for soft-tissue adhesive10.3389/fchem.2021.744099 ↗
44. Scaffolds in tissue engineering bone and cartilage10.1016/S0142-9612(00)00121-6 ↗
45. A vision on the future of articular cartilage repair
46. Cartilage repair with chondrocytes in fibrin hydrogel and MPEG polylactide scaffold: an in vivo study in goats10.1007/s00167-008-0522-1 ↗
47. Autologous cartilage fragments in a composite scaffold for one stage osteochondral repair in a goat model10.22203/eCM.v026a02 ↗
48. Fixation of hydrogel constructs for cartilage repair in the equine model: a challenging issue10.1089/ten.tec.2017.0200 ↗
49. Surgical suturing of articular cartilage induces osteoarthritis-like changes10.1016/j.joca.2008.01.009 ↗
50. Quality of scaffold fixation in a human cadaver knee model10.1016/j.joca.2009.09.001 ↗
51. Cartilage repair: synthetics and scaffolds: basic science, surgical techniques, and clinical outcomes10.1097/JSA.0b013e31818cdbaa ↗
52. Sterilization of hydrogels for biomedical applications: a review10.1002/jbm.b.34048 ↗
53. Thermomechanical properties, antibiotic release, and bioactivity of a sterilized cyclodextrin drug delivery system10.1039/C4TB00083H ↗
54. Guideline on the sterilisation of the medicinal product, active substance, excipient and primary container, Committee for Medicinal Products for Human use (CHMP), Committee for Medicinal Products for Veterinary use (CVMP) (EMA/CHMP/CVMP/QWP/850374/2015) (2019).
55. Commercialization and regulation of regenerative medicine products: promises, advances and challenges10.1016/j.biopha.2022.113431 ↗
56. ISO 18362:2016, Manufacture of Cell-Based Health Care Products - Control of Microbial Risks During Processing.
57. ISO 13408-1:2008, Aseptic Processing of Health Care Products — Part 1: General Requirements.
58. Guidance for Industry, Sterile Drug Products Produced by Aseptic Processing-Current Good Manufacturing Practice, FDA-2003-D-0145, 2004.
59. ISO 11737-2:2019, Sterilization of Health Care Products — Microbiological Methods — Part 2: Tests of Sterility Performed in the Definition, Validation and Maintenance of a Sterilization Process.
60. Long-term and short-term preservation strategies for tissue engineering and regenerative medicine products: state of the art and emerging trends10.1093/pnasnexus/pgac212 ↗
61. Advanced biomaterials in cell preservation: hypothermic preservation and cryopreservation10.1016/j.actbio.2021.07.001 ↗
62. ASTM F2739-19, Standard Guide for Quantifying Cell Viability and Related Attributes within Biomaterial Scaffolds.
63. The benefits and limitations of animal models for translational research in cartilage repair10.1186/s40634-015-0037-x ↗
64. Animal models for cartilage regeneration and repair10.1089/ten.teb.2009.0452 ↗
65. On the predictive utility of animal models of osteoarthritis10.1186/s13075-015-0747-6 ↗
66. Animal models of cartilage repair10.1302/2046-3758.34.2000238 ↗
67. Perspectives on animal models utilized for the research and development of regenerative therapies for articular cartilage10.1007/s40610-016-0038-2 ↗
68. Reduction of sample size requirements by bilateral versus unilateral research designs in animal models for cartilage tissue engineering10.1089/ten.tec.2012.0699 ↗
69. Animal models of osteochondral defect for testing biomaterials10.1155/2020/9659412 ↗
70. International · 2005
71. Expandable scaffold improves integration of tissue-engineered cartilage: an in vivo study in a rabbit model10.1089/ten.tea.2015.0510 ↗
72. Large animal models in regenerative medicine and tissue engineering: to do or not to do10.3389/fbioe.2020.00972 ↗
73. Animal models of osteoarthritis: comparisons and key considerations10.1177/0300985815588611 ↗
74. Matrix-induced autologous chondrocyte implantation in sheep: objective assessments including confocal arthroscopy10.1002/jor.20502 ↗
75. Cartilage tissue engineering approaches need to assess fibrocartilage when hydrogel constructs are mechanically loaded
76. Chondroitinase ABC enhances integration of self-assembled articular cartilage, but its dosage needs to be moderated based on neocartilage maturity10.1177/1947603520918653 ↗
77. Cartilage integration: evaluation of the reasons for failure of integration during cartilage repair. A review10.22203/eCM.v016a04 ↗
78. Polymeric mesh and insulin-like growth factor 1 delivery enhance cell homing and graft− cartilage integration10.1111/nyas.14054 ↗
79. Multifunctional chondroitin sulphate for cartilage tissue–biomaterial integration10.1038/nmat1890 ↗
80. Cyst formation in the subchondral bone following cartilage repair10.1002/ctm2.248 ↗
81. Magnetic resonance imaging of cartilage repair: a review10.1177/1947603509360209 ↗
82. State of the art: MR imaging after knee cartilage repair surgery10.1148/radiol.2015141146 ↗
83. Articular cartilage in the knee: current MR imaging techniques and applications in clinical practice and research10.1148/rg.311105084 ↗
84. Quantitative MRI techniques of cartilage composition
85. Relationship between T1rho magnetic resonance imaging, synovial fluid biomarkers, and the biochemical and biomechanical properties of cartilage10.1016/j.jbiomech.2017.02.001 ↗
86. Longitudinal femoral cartilage T2 relaxation time and thickness changes with fast sequential radiographic progression of medial knee osteoarthritis—data from the osteoarthritis initiative (OAI)10.3390/jcm10061294 ↗
87. Exploration of MRI T2 mapping image application in articular disc displacement of the temporomandibular joint in adolescents10.2147/IJGM.S330116 ↗
88. Gadolinium-hyaluronic acid nanoparticles as an efficient and safe magnetic resonance imaging contrast agent for articular cartilage injury detection
89. Micro-CT–a digital 3D microstructural voyage into scaffolds: a systematic review of the reported methods and results10.1186/s40824-018-0136-8 ↗
90. Cartilage morphology assessed by high resolution micro-computed tomography in non OA knees10.1016/j.joca.2015.10.009 ↗
91. Bioprinting of radiopaque constructs for tissue engineering and understanding degradation behavior by use of Micro-CT
92. Non-invasive deep tissue imaging of iodine modified poly (caprolactone-co-1-4-oxepan-1, 5-dione) using X-ray10.1016/j.actbio.2015.03.021 ↗
93. X-ray computed tomography10.1038/s43586-021-00015-4 ↗
94. Histochemical studies of the extracellular matrix of human articular cartilage—a review10.1053/joca.2002.0519 ↗
95. Basic methods in histopathology of joint tissues10.1016/j.joca.2010.05.026 ↗
96. Cryoembedding and sectioning of cochleas for immunocytochemistry and in situ hybridization10.1016/S1385-299X(00)00048-9 ↗
97. Effects of delayed treatment with combined GDNF and continuous electrical stimulation on spiral ganglion cell survival in deafened guinea pigs10.1002/jnr.21964 ↗
98. Deafferentiation-associated changes in afferent and efferent processes in the guinea pig cochlea and afferent regeneration with chronic intrascalar brain-derived neurotrophic factor and acidic fibroblast growth factor10.1002/cne.21619 ↗
99. Polyester wax: a new embedding medium for the histopathologic study of human temporal bones10.1097/01.mlg.0000192171.85406.47 ↗
100. Methyl methacrylate embedding to study the morphology and immunohistochemistry of adult guinea pig and mouse cochleae10.1016/j.jneumeth.2015.07.017 ↗